UNSPSC 51172334: Trientine hydrochloride

This classification denotes a metal chelator, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HC3NX54582. European Medicines Agency schedules Trientine dihydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04953MIG. Trientine hydrochloride generally arises in the molecular formula C6H18N4.2CLH. The term 'trientine hydrochloride' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule trientine hydrochloride under HS 29212900.

As of Q4 2014, TRIENTINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Trientine hydrochloride bears US NLM identifiers UMLS ID C0770325 and NCI Concept Code C61987. SMILES: C(CNCCNCCN)N.CL.CL.

UNSPSC 51172334 Trientine hydrochloride is a Commodity code that encompasses specific pharmaceutical active ingredients and their use in treatment protocols, though recent state and local solicitations show limited direct activity tagged to this code. The recent opportunities block contains three entries, but only the Texas Health and Human Services Commission RFI regarding Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions (HHS0017013, posted April 3, 2026) and the Minnesota Multistate Cooperative Purchasing Alliance pharmaceutical RFP (S1070000015802, posted January 20, 2026) involve pharmaceutical procurement at scale; the Collin County drug-testing RFP concerns specimen collection and screening services rather than trientine hydrochloride itself. The MMCAP solicitation targets generic multi-source pharmaceuticals and OTC products through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co., LLC), with proposals due March 26, 2026, and no specific mention of trientine or other specialty agents in the available summary. The Texas HHS RFI is exploratory, seeking vendor capabilities for direct-to-manufacturer prescription fulfillment without formal competitive criteria or award values at that stage.

Issuing bodies active in pharmaceutical procurement at this tier include state health agencies (Texas Health and Human Services Commission) and multi-state cooperative purchasing alliances administered by state procurement offices (Minnesota Department of Administration). Geographic activity is concentrated in Texas and Minnesota, with MMCAP's reach extending to Oregon and other participating jurisdictions. The code shows minimal targeted activity under trientine hydrochloride specifically; recent pharmaceutical solicitations focus on generic multi-source products, OTC items, and broad direct-contracting capability rather than named active pharmaceutical ingredients. If your firm supplies trientine or specialty therapeutics through existing pharmaceutical distribution channels, the MMCAP cooperative vehicle and similar multi-state purchasing consortia merit monitoring, though current posted opportunities do not isolate demand for this specific compound.